An interventional study of Graphene oxide and open flap debridement and Open flap debridement in Periodontal Diseases, sponsored by Ain Shams University. Status unknown. Open to male participants aged 1 Year to 2 Years. Per ClinicalTrials.gov, last updated 2022-04-22.
Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment
Using Graphene oxide in the surgical management of periodontal intrabony defects.
Evaluation of the effect of Graphene oxide in the surgical management of periodontal intrabony defects in animals in periodontal clinical parameters with histomorphometric evaluation .
855 studies on the registry are indexed under Periodontal Diseases; 189 are open to participants now.
This study's planned enrollment of 6 is below the median of 45 across 546 interventional studies indexed under Periodontal Diseases.
Browse Periodontal Diseases studies →Ain Shams University is the lead sponsor of 1,930 studies on the registry; 433 are open to participants now.
Of its 33 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
The surgical defect will be managed by open flap debridement and application of Graphene oxide
Procedure: Graphene oxide and open flap debridement
The surgical defect will be managed by open flap debridement
Procedure: Open flap debridement
Using Graphene oxide with open flap debridement in management of periodontal intrabony defects in dogs
Using Open flap debridement in management of periodontal intrabony defects in dogs
periodontal probing depth
To evaluate the use of Graphene Oxide in the surgical management of intrabony periodontal defects regarding the changes in periodontal probing depth "measured in mm " using University of North Carolina periodontal probe( UNC 15 probe ).
Time frame: 2 months
Clinical attachment level
To evaluate the use of Graphene Oxide in the surgical management of intrabony periodontal defects regarding the changes in clinical attachment level "measured in mm " using University of North Carolina periodontal probe( UNC 15 probe )
Time frame: 2 month
Histomorphometric evaluation
To evaluate the use of Graphene Oxide in the surgical management of intrabony periodontal defects using histological sections obtained from the surgical site to do quantitative assessment of bone remodeling, modeling, and structure by "counting the number of osteoblasts and the number of bone trabeculae " using computer based microscope and software.
Time frame: 2 months
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for May 2022; primary completion for May 2023, 12 months later.
Of 308 non-industry interventional studies with no phase under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's planned 12 months is close to that.
Counting every sponsor, half of 326 studies reached it within 13 months; a quarter within 7 and three quarters within 25.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.